Can a Thyroid Nodule Be Treated Without Surgery?
Can a Thyroid Nodule Be Treated Without Surgery? Yes — most benign thyroid nodules can now be treated without surgery For decades, the standard answer to a symptomatic thyroid nodule was surgical removal — either the nodule, part of the thyroid, or the entire gland. That is no longer the only option. Radiofrequency ablation (RFA) and microwave ablation (MWA) are non-surgical procedures that shrink thyroid nodules from the inside, preserving the thyroid gland entirely. Most patients with benign nodules are never told this option exists. This article explains what it is, who qualifies, what the results look like, and how it compares to surgery. What Is a Thyroid Nodule? A thyroid nodule is a discrete growth within the thyroid gland — a solid or fluid-filled lump that develops within the thyroid tissue. They are extremely common. Thyroid nodules are present in up to 65% of the general population when assessed with high-resolution ultrasound, though most are small and cause no symptoms. The majority of thyroid nodules are benign. Fewer than 5% are malignant. The clinical challenge is identifying which nodules require treatment and which can be safely monitored. How nodules are assessed — TIRADS and FNAC When a thyroid nodule is found on imaging, the standard assessment uses two tools: TIRADS (Thyroid Imaging Reporting and Data System) — TIRADS score determines whether FNAC is indicated. A standardised scoring system applied during ultrasound. It classifies nodules from TIRADS 1 (normal) to TIRADS 5 (high suspicion for malignancy) based on their ultrasound characteristics: composition, echogenicity, shape, margins, and echogenic foci. TIRADS score determines whether biopsy is indicated. FNAC (Fine Needle Aspiration Cytology) — A thin needle is inserted under ultrasound guidance into the nodule. FNAC classifies the nodule as benign, indeterminate, suspicious, or malignant. This result determines the treatment pathway. Benign nodules confirmed on FNAC — particularly those causing symptoms due to their size — are the primary candidates for non-surgical ablation. When Does a Thyroid Nodule Need Treatment? Not every thyroid nodule requires intervention. Active surveillance — monitoring with periodic ultrasound — is appropriate for nodules that are small, stable, and asymptomatic. Treatment is indicated when any of the following apply: The nodule is causing compressive symptoms: difficulty swallowing, a sensation of pressure in the neck, hoarseness, or difficulty breathing The nodule is cosmetically significant — visible as a lump in the neck and causing distress The nodule is a functioning (autonomously hyperfunctioning) nodule producing excess thyroid hormone The nodule is growing on serial ultrasound — an increase of 20% or more in two dimensions FNAC results are indeterminate and the clinical picture warrants treatment over continued surveillance Historically, any of these presentations led to a surgical referral. For most patients, that is no longer necessary. What Is Thyroid RFA — Radiofrequency Ablation? Radiofrequency ablation (RFA) is a minimally invasive, non-surgical procedure that destroys thyroid nodule tissue using controlled heat delivered through a thin electrode needle. How the procedure works: Local anaesthetic is applied to the neck — no general anaesthesia is required A thin electrode needle is inserted into the nodule under continuous ultrasound guidance Radiofrequency energy is delivered through the needle tip, generating controlled heat within the nodule tissue The heat destroys the nodule cells while the surrounding normal thyroid tissue is preserved The procedure uses a ‘moving shot’ technique — the needle is repositioned within the nodule to ensure complete coverage Total procedure time is typically 30–60 minutes No incision. No stitches. No hospital stay required for most patients What happens after RFA: The treated nodule does not disappear immediately. Over the following weeks and months, the destroyed tissue is gradually absorbed and replaced by scar tissue. The nodule shrinks progressively: At 1 month: 30–40% volume reduction At 6 months: 50–80% volume reduction At 12 months: sustained reduction, with some nodules reducing by over 90% Compressive symptoms — difficulty swallowing, pressure — typically improve within weeks as the nodule begins to shrink. The thyroid gland remains intact and continues to function normally. What Is Microwave Ablation (MWA)? Microwave ablation uses microwave energy rather than radiofrequency to achieve the same result — controlled thermal destruction of nodule tissue. The mechanism differs slightly: MWA generates a larger ablation zone per application and reaches target temperature faster. Clinical outcomes are comparable between RFA and MWA. The choice between the two depends on nodule characteristics — size, location, vascularity — and operator expertise. Both are performed under ultrasound guidance, under local anaesthesia, without surgery. What Is Microwave Ablation (MWA)? Thyroid RFA / MWA Surgery (Thyroidectomy) Anaesthesia Local General Incision / scar None Yes — neck incision Hospital stay Day Care procedure 2–4 days Recovery time Recovery is immediate 1 week Thyroid preserved Yes Partial or complete removal Lifelong medication Usually not required Required if gland fully removed Nodule recurrence Extremely rare Minimal (gland removed) Risk to vocal nerves Very low Small but present Who Is a Candidate for Thyroid RFA? RFA is appropriate for most patients with benign, symptomatic thyroid nodules. Specifically, you are likely a good candidate if: Your nodule has been confirmed benign on FNAC The nodule is causing compressive symptoms or is cosmetically significant You want to preserve your thyroid gland and avoid lifelong thyroid hormone replacement You are not a suitable candidate for surgery due to other health conditions You had a previous thyroid surgery and have a recurrent nodule RFA is not appropriate for malignant nodules. Confirmed thyroid cancer requires surgical management in most cases, though RFA may have a role in specific scenarios — particularly recurrent or metastatic disease in inoperable patients, assessed on a case-by-case basis. Indeterminate FNAC results require individual clinical judgment. RFA is presented as an alternative to diagnostic surgery, but FNAC remains the recommended path. Key point on thyroid function after RFA: Because RFA targets only the nodule — not the surrounding gland — thyroid function is preserved in the vast majority of patients. Post-procedure thyroid hormone levels typically remain within normal range. This is one of the most significant advantages



